1. International Scientific Committee of Ozone Therapy. Madrid declaration on ozone therapy: ISCO3, 3rd edition. Published 2020. Accessed March 9, 2026. https://isco3.org/madrid-declaration-on-ozone-therapy-isco3-3rd-edition-2020-103-pages/
2. International Scientific Committee of Ozone Therapy. Definitions of terms in ozone therapy. Published 2019. Accessed March 9, 2026. https://isco3.org/wp-content/uploads/2015/09/ISCO3-QAU-00-04-Definitios-and-terms-in-O3-Final.pdf
3. International Scientific Committee of Ozone Therapy. Major autohemotherapy. Published October 3, 2016. Accessed March 9, 2026. https://isco3.org/wp-content/uploads/2017/03/ISCO3-MET-00-01-MAHT-V1-03102016.pdf
4. International Scientific Committee of Ozone Therapy. Non-recommended routes of application in ozone therapy. Published September 5, 2017. Accessed March 9, 2026. https://isco3.org/wp-content/uploads/2015/09/Non-recommended-routes.pdf
5. Martínez Sánchez G, Schwartz A, Quintero Mariño R, Sabbah F. Non-recommended routes of application in ozone therapy, a critical review. Rev Esp Ozonoterapia. 2018;8(1):19-35. Accessed March 9, 2026. https://dialnet.unirioja.es/servlet/articulo?codigo=6553910
6. Hidalgo-Tallón FJ, Torres-Morera LM, Baeza-Noci J, Carrillo-Izquierdo MD, Pinto-Bonilla R. Updated review on ozone therapy in pain medicine. Front Physiol. 2022;13:840623. doi:10.3389/fphys.2022.840623
7. Armenteros-Yeguas V, Gárate-Echenique L, Tomás-López MA, et al. Prevalence of difficult venous access and associated risk factors in highly complex hospitalised patients. J Clin Nurs. 2017;26(23-24):4267-4275. doi:10.1111/jocn.13750
8. Paterson RS, Schults JA, Slaughter E, et al. Peripheral intravenous catheter insertion in adult patients with difficult intravenous access: a systematic review of assessment instruments, clinical practice guidelines and escalation pathways. Emerg Med Australas. 2022;34(6):862-870. doi:10.1111/1742-6723.14069
9. Newcombe RG. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med. 1998;17(8):873-890. doi:10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I
10. Tertemiz OF, Ozduran E, Gursoy S, et al. Effect of major ozone autohemotherapy in fibromyalgia syndrome: a retrospective study. PeerJ. 2025;13:e20475. doi:10.7717/peerj.20475
11. Gazioğlu Türkyılmaz G, Rumeli Ş, Bakır M. Effects of major ozone autohemotherapy on physical functionality and quality of life in fibromyalgia syndrome: a prospective cross-sectional study. Altern Ther Health Med. 2021;27(5):8-12.
12. Ahi ED, Afsar SI. The effectiveness of major ozone autohemotherapy in the treatment of fibromyalgia syndrome: major ozone autohemotherapy in the treatment of fibromyalgia. J Surg Med. 2022;6(8):746-750. doi:10. 28982/josam.1032050
13. Bocci V. The clinical application of ozonetherapy. In: Bocci V. Ozone: a new medical drug. 2nd ed. Springer; 2011:97-232. doi:10.1007/978-90-481-9234-2_9
14. Wong CYY, Saxena K, Meneer J, George K, Keijzers G. Neurological crisis following intravenous ozone therapy; a case report. Arch Acad Emerg Med. 2025;13(1):e31. doi:10.22037/aaemj.v13i1.2592
15. Khosravi S, Mirzaasgari Z. Cerebral gas embolism and multifocal ischemic stroke during oxygen-ozone therapy: a case report. BMJ Neurol Open. 2024;6(2):e000885. doi:10.1136/bmjno-2024-000885
16. Freund PR, Alshafai L, Margolin EA. Multifocal stroke from ozone gas emboli. J Neuroophthalmol. 2019;39(4):518-519. doi:10.1097/WNO.0000 000000000754
17. He R, Huang Q, Yan X, Liu Y, Yang J, Chen X. A case of paradoxical embolism causing anterior spinal cord syndrome and acute myocardial infarction following the intradiscal oxygen-ozone therapy. Front Neurol. 2019;10:137. doi:10.3389/fneur.2019.00137